Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-12-31

Clinical Trial Update: Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation [NA]

View source ↗

Summary

A clinical trial evaluating MIC/breakpoint ratio and tissue penetration for skin and soft tissue infections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federico II University | Conditions: Infection of Skin and/or Subcutaneous Tissue | NA | Status: WITHDRAWN